CD274 and neoplasm: It inhibits the recruitment of myeloid-derived suppressor cells (MDSCs) into tumors, decreases the expression of PD-L1 on the tumor surface, and achieves a superior tumor growth inhibition rate compared to conventional fractionation (38).